Shree Pacetronix (SHREEPAC) | Stock Overview & Key Data
Shree Pacetronix Performance Comparison
Stock Range
Today's Range
Low: ₹216.00
High: ₹216.00
on September 18, 2025
52 Week Range
Low: ₹61.11
High: ₹216.00
on March 28, 2025
on September 18, 2025
All-Time High: ₹391.90 on November 6, 2023
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR747.4M
EPS
2.89
P/E Ratio (TTM)
70.45
Forward P/E
N/A
P/B Ratio
5.33
PEG Ratio
0.88
Div. Yield
N/A
ROE
5.44%
Beta
-1.614
Debt to Equity
36.79
Financial Highlights
Profitability
Gross Margin
68.11%
Operating Margin
18.43%
Profit Margin
6.03%
Returns and Earnings
Return on Assets (TTM)
3.25%
Return on Equity (TTM)
5.44%
EBITDA
INR27.8M
Net Income (TTM)
INR10.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR48.04
Quarterly Revenue Growth (YoY)
10.10%
Quarterly Earnings Growth (YoY)
78.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Shree Pacetronix SHREEPAC | 747.42M Small-cap | 10.34% | 41.45% | 160.52% | 214.57% | 67.17% | 31.76% | 258.98% | 1,580.95% |
| Poly Medicure POLYMED | 201.64B Large-cap | 2.52% | 5.11% | -7.50% | -9.76% | -25.50% | -14.73% | 123.03% | 339.59% |
| Dr Agarwal's Health AGARWALEYE | 138.90B Mid-cap | 2.85% | 0.79% | 11.15% | 5.44% | 9.31% | 9.20% | 9.20% | 9.20% |
| Laxmi Dental LAXMIDENTL | 19.92B Small-cap | 12.28% | 1.45% | -16.21% | -17.74% | -35.71% | -31.15% | -31.15% | -31.15% |
| Tarsons Products TARSONS | 16.74B Small-cap | -0.10% | -7.58% | -18.11% | 10.67% | -22.49% | -34.45% | -61.02% | -61.59% |
| Prevest Denpro PREVEST | 7.19B Small-cap | -3.11% | 7.00% | 22.03% | 42.72% | -2.78% | 0.92% | 40.22% | 120.11% |
Ownership & Short Interest
Insider Ownership
58.84%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
13K
Average 90-Day Volume
17K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SHREEPAC's 52-week high and low?
- In the last 52 weeks, Shree Pacetronix reached a high of ₹216.00 (on September 18, 2025) and a low of ₹61.11 (on March 28, 2025).
- What is the market cap and P/E ratio for SHREEPAC?
- Curious about Shree Pacetronix's size and valuation? Its market capitalization stands at 747.42M. When it comes to valuation, the P/E ratio (trailing twelve months) is 70.45, and the forward P/E (looking ahead) is N/A.
- Does SHREEPAC pay dividends? If so, what's the yield?
- As for dividends, Shree Pacetronix isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Shree Pacetronix's main competitors or similar companies to consider before investing?
When looking at Shree Pacetronix, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Poly Medicure
POLYMED201.64B Healthcare Medical Instruments & Supplies -14.73% 123.03% Dr Agarwal's Health
AGARWALEYE138.90B Healthcare Medical Instruments & Supplies 9.20% 9.20% Laxmi Dental
LAXMIDENTL19.92B Healthcare Medical Instruments & Supplies -31.15% -31.15% Tarsons Products
TARSONS16.74B Healthcare Medical Instruments & Supplies -34.45% -61.02% Prevest Denpro
PREVEST7.19B Healthcare Medical Instruments & Supplies 0.92% 40.22% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Shree Pacetronix Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Shree Pacetronix's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.44%, the Debt to Equity ratio from the most recent quarter is 36.79, and its Gross Profit Margin stands at 68.11%.
- What is the recent revenue and earnings growth for SHREEPAC?
- Looking at Shree Pacetronix's growth, its revenue over the trailing twelve months (TTM) was INR173M. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.10%, and quarterly earnings saw a YoY growth of 78.40%.
- How much of SHREEPAC stock is held by insiders and institutions?
- Wondering who owns Shree Pacetronix stock? Company insiders (like executives and directors) hold about 58.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.